(Don’t Fear) The Partner: Why Signing An Early Strategic Biotech Partnership is Not the Beginning of the End
Here are three common fears regarding early-stage strategic partnerships, and ways a founder or investor can overcome them to be successful.
top of page
My Thoughts
Leveraging my experience as a co-founder of a biotechnology start-up, corporate development leader, and investor to discuss tactical and strategic considerations for building great biotech and pharma companies.
Search
bottom of page